The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP)
Syed Ali, MD
The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone, and enzalutamide with enzalutamide alone on you and your prostate cancer to find out which is better.
Leslie Howard, MD
Cancer - Prostate,
Cancer
- D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
-
Baystate Franklin Medical Center, 164 High Street, Greenfield, MA
This randomized phase III trial studies lenalidomide, dexamethasone, and bortezomib to see how well it works compared to dexamethasone and lenalidomide alone in treating patients with previously untreated multiple myeloma. Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the cancer. It is not yet known whether lenalidomide and dexamethasone is more effective with or without bortezomib in treating multiple myeloma.
Syed Ali, MD
Cancer - Leukemia,
Cancer
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
Seth Kaufman, MD
Cancer - Esophogus,
Cancer
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
The purpose of this study is to find out if the drug combination of paclitaxel, carboplatin and metformin works better than paclitaxel and carboplatin alone and to find out what side effects are caused by treatment with these drugs.
Tashanna Myers, MD
Cancer-Gynecologic,
Cancer
- D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
- Baystate Franklin Medical Center, 164 High Street, Greenfield, MA
Page 1 of 6 | Results 1 - 10 of 55